Information for Healthcare Providers – Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and the Pease Study
INFORMATION TO PROTECT OUR COMMUNITIES
We do not know. But, the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) are beginning a study in the fall of 2019 to learn how PFAS, a group of human-made chemicals, may have affected the health of people exposed through PFAS-contaminated drinking water in Pease International Tradeport’s public water system and some nearby private wells.
Scientists are still learning how PFAS exposure affects human health, but some studies have shown that PFAS may:
- Interfere with the body’s natural hormones;
- Increase cholesterol levels;
- Affect the immune system; and
- Increase the risk of some cancers.
Since the 1950s, PFAS has been used worldwide to make a wide-range of industry and consumer products, including grease-, water-, and oil-resistant products, and firefighting foams used at the former Pease Air Force Base in Portsmouth, New Hampshire.
The Pease Study will expand the PFAS-science base by looking for possible links between health outcomes and PFAS exposure. Healthcare providers can find more information and learn more about the Pease Study at www.atsdr.cdc.gov/pfas.
Who may participate in the Pease Study?
Pease Study eligibility requires meeting the following criteria:
An adult aged 18 or older who
- worked or attended school at Pease International Tradeport at anytime from January 2004 to May 2014, or
- lived in Newington at anytime from January 2004 to the present and used a private well with documented PFAS contamination.
A child aged 4 through 17 who has parent or guardian permission and
- attended daycare at Pease International Tradeport at anytime from January 2004 to May 2014, or
- was born to and/or breastfed by a mother who meets the adult eligibility criteria.
A small group of adults who never drank water from Pease International Tradeport and whose occupation or education did not expose them to PFAS, and children who never drank water from Pease International Tradeport may also be eligible to participate.
What does participation include?
Participants will provide information on their exposure to PFAS, medical history, a urine sample, allow a phlebotomist to draw a blood sample after fasting 8 hours, and have their body measurements taken. Child participants will also receive a behavioral assessment.
CDC and ATSDR will protect all personal information and conceal each participant’s identity.
Why should individuals participate?
Participation helps communities in many ways. Everyone benefits from increasing scientific knowledge of how PFAS may affect human health. Participants will receive their individual test results, which they can share with their healthcare providers. Additionally, participants will get a $25 gift card for completing each part of the study (up to $75 for completing all three parts).
How will CDC and ATSDR share results?
CDC and ATSDR will mail participants their PFAS screening results, but it take up to two years before results arrive. PFAS test analysis takes a long time. CDC and ATSDR will also publish and share reports on the community-level data publicly when the study ends. These reports will not include participants’ private, identifiable information.
As a healthcare provider, where can I find current information on PFAS exposure studies and PFAS health effects?
A number of resources are available to you and your patients.
- Find CDC and ATSDR clinician information for many common questions, including potential human health effects, current or future health problems, and pregnancy, and breastfeeding concerns at: www.atsdr.cdc.gov/pfas/info-for-health-professionals.html.
- Take the PFAS Continuing Education for Clinicians training and receive continuing education credits, available at: https://www.atsdr.cdc.gov/emes/pfas_clinicians_training.html.
- Instruct people to find more information on PFAS and the Pease Study on the CDC and ATSDR websites or to call the information hotline: www.atsdr.cdc.gov/pfas, or call 800-CDC-INFO; TTY 888-232-6348.
- Obtain information on PFAS-related activities in the Portsmouth area by calling the CDC and ATSDR Regional Office, 617-918-1493 or email email@example.com.
Understanding the relationship between exposure and health outcomes can better prepare and encourage community members to follow up with healthcare providers and monitor their health.
CDC and ATSDR will integrate data from the Pease Study with data from other sites to maximize the impact and provide information to communities across the nation.